News in the Life Sciences Industry

OCEANSIDE, Calif., June 19, 2019 /PRNewswire/ -- AOTI Inc. today announced that it has been awarded a new five-year Federal Supply Schedule (FSS) contract for its patented Topical Wound Oxygen (TWO(2)) therapy by the National Acquisition Center, U.S. Department of Veterans Affairs (VA).

Rise in prevalence of various diseases, surge in R&D activities in healthcare coupled with increase in adoption of early toxicity testing, advantages offered by biomarker in drug development, and rapid escalation in genome mapping programs drive the growth of the global biomarker technologies... Read more ››

SAN MATEO, Calif., June 19, 2019 /PRNewswire/ -- Wonder Workshop, maker of educational robots Dash, Dot, and Cue, which are now used... Read more ››

NEW YORK, June 19, 2019 /PRNewswire/ -- TMRW, creator of the first Robotic Process Automation (RPA) platform specifically for in vitro fertilization (IVF), announced today that Emily Drabant Conley, Ph.D., Vice President, Business Development at 23andMe, has been named to the company's Board... Read more ››

JANESVILLE, Wis., June 19, 2019 /PRNewswire/ -- Phoenix, LLC, a Madison, WI nuclear technology company, and SHINE Medical Technologies, a Janesville, WI medical isotope production company, today announced completion of a 132-hour test of the high-flux Phoenix neutron generator that will... Read more ››

SOUTH SAN FRANCISCO, Calif., June 19, 2019 /PRNewswire/ -- Portola Pharmaceuticals, Inc.(®) (Nasdaq: PTLA) today announced new interim results from the Company's ongoing Phase 2a study of cerdulatinib, an investigational, oral SYK/JAK inhibitor, in patients with relapsed/refractory follicular... Read more ››

RESTON, Va., June 19, 2019 /PRNewswire/ -- A new study performed in conjunction with the Harvey L. Neiman Health Policy Institute examines changing characteristics of utilization and potential disparities in US emergency department (ED) patients undergoing CT of the abdomen and pelvis (CTAP)... Read more ››

WASHINGTON, June 19, 2019 /PRNewswire/ -- Since the China launch earlier this year of an immuno-oncology drug at one-third the price of Merck's Keytruda, there has been a wave of applications for affordable innovative therapies from China, developed to Western standards of safety and efficacy,... Read more ››

INDIANAPOLIS, June 19, 2019 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the third quarter of 2019 of $0.645 per share on outstanding common stock.